SHIRLEY, NY – Dec 25, 2018 – Creative Proteomics, a leading supplier in drug development services, recently announces that they have upgraded four services related to protein research projects. The updated service ranges include four: protein quantification service, iTRAQ-based proteomics analysis, SILAC-based proteomics analysis, and absolute quantification (AQUA).
Protein Quantification Service
Discovery-based quantitative proteomics compares the proteome of a diseased sample versus normal at a global scale, and has been widely used to study various human diseases with the goal to identify biomarkers and reveal the pathogenesis of diseases. Methods for acquiring quantitative proteomics data are continually developing with very accurate stable isotope labeling (SIL) and label-free approaches. As one of the leading proteomics industry company, Creative Proteomics now is opening to provide a series of protein quantification services for customers with accurate and reliable results.
iTRAQ-based Proteomics Analysis
Creative Proteomics offers iTRAQ protein quantification service suited for unbiased untargeted biomarker discovery. Relative quantification of proteins for biomarker discovery in complex mixtures by mass spectrometry can easily and quickly be achieved using iTRAQ technology. iTRAQ is ideally suited for comparing normal, diseased, and drug-treated samples, time course studies, biological replicates and provides relative quantitation.
SILAC-based Proteomics Analysis
SILAC-based quantitative proteomics (SILAQ) is an innovative technology used in high throughput quantitative analysis of large protein complexes, protein-protein and protein-small molecule interactions. SILAC service of Creative Proteomics provides an unbiased strategy that can reveal how specifically either inhibitors, or other perturbations, affect the dynamic properties and cellular distributions of proteins. It can also be used as a sensitive and effective method to determine the specific interaction partners of proteins in the cell.
Absolute Quantification (AQUA)
The upgraded absolute quantification is a targeted quantitative proteomics technique that exhibits robust efficacy and is being increasingly utilized for a wide variety of quantitative proteomics studies. AQUA strategy is for the absolute quantification (AQUA) of proteins and their modification states. Peptides are synthesized with incorporated stable isotopes as ideal internal standards to mimic native peptides formed by proteolysis. These synthetic peptides can also be prepared with covalent modifications that are chemically identical to naturally occurring posttranslational modifications. Such AQUA internal standard peptides are then used to precisely and quantitatively measure the absolute levels of proteins and post-translationally modified proteins after proteolysis by using a selected reaction monitoring analysis in a tandem mass spectrometer.
“Creative Proteomics concentrates on supplying the high-quality services and products for labs and research institutes. We guarantee the developed products and services, which are customized, can meet the demands of our clients, who believe in our scientists and Creative Proteomics”, said Dr. Charlie.
About Creative Proteomics
Creative Proteomics is programming a full range of services to support various proteome-related researches from identification of single proteins to large-scale proteomic studies. The advancement of our proteomics analysis platforms and our specialized employees allows us to provide efficient high throughput and super-sensitivity services. Our team is committed to providing you with the optimal service for your research needs basing at the lowest cost level in the industry.
More information is available at Creative Proteomics website.
Company Name: Creative Proteomics
Contact Person: Melissa George
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States